Donate
Research
Research

1996

Melatonin and Sleep in Angelman Syndrome

Drug Trial
Sleep
Share

$10,000

This research grant determined if melatonin, a well-known drug that has been used to improve sleep, could be effective in individuals with Angelman syndrome (AS). Children with AS were monitored at night using motion detecting devices and sleep observations. This study showed positive results and its findings helped lead to the established therapeutic use of melatonin to help improve sleep in AS.

Facebook Instagram Linkedin Rss Youtube X-twitter

The mission of Angelman Syndrome Foundation is to advance the awareness and treatment of Angelman syndrome through education and information, research and support for individuals with Angelman syndrome, their families and other concerned parties. We exist to give all of them a reason to smile, with the ultimate goal of finding a cure.

Donate